Terns Pharmaceuticals, Inc. Share Price
TERNTerns Pharmaceuticals, Inc. Stock Performance
Open $27.15 | Prev. Close $26.90 | Circuit Range N/A |
Day Range $26.54 - $28.16 | Year Range $1.86 - $29.38 | Volume 2,15,360 |
Average Traded $27.26 |
Terns Pharmaceuticals, Inc. Share Price Chart
About Terns Pharmaceuticals, Inc.
Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule product candidates for the treatment of oncology and obesity. The company develops TERN-701, an allosteric BCR-ABL tyrosine kinase inhibitor (TKI) that is in Phase 1 clinical trial for chronic myeloid leukemia (CML), a form of cancer that starts in bone marrow. It also develops TERN-501, a thyroid hormone receptor beta agonist with enhanced liver distribution and metabolic stability that is in Phase IIa clinical trial for the treatment of metabolic dysfunction-associated steatohepatitis (MASH); and TERN-601, a small-molecule Glucagon-Like Peptide-1 receptor agonist program that is intended to orally be administered for obesity, as well as TERN-800 series of small-molecule glucose-dependent insulinotropic polypeptide receptor (GIPR) modulators for obesity. The company was incorporated in 2016 and is headquartered in Foster City, California.
Terns Pharmaceuticals, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
04-Dec-25 | $27.15 | $27.05 | +0.00% |
04-Dec-25 | $27.15 | $27.05 | +4.91% |
02-Dec-25 | $27.78 | $25.79 | -6.29% |
01-Dec-25 | $27.99 | $27.52 | -2.26% |
28-Nov-25 | $28.75 | $28.15 | -2.05% |
26-Nov-25 | $29.35 | $28.74 | -2.11% |
25-Nov-25 | $28.69 | $29.36 | +4.71% |
FAQs on Terns Pharmaceuticals, Inc. Share Price
Can I buy Terns Pharmaceuticals, Inc. shares in India?
What is the share price of Terns Pharmaceuticals, Inc.?
What is the 5 year returns of Terns Pharmaceuticals, Inc.?
What are the high & low stock price of Terns Pharmaceuticals, Inc. today?
What is the 52-week high and low of Terns Pharmaceuticals, Inc. stock?